Collaxio (COLLAX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Substantial recovery in Q3 2024, with total comprehensive income of 12,636 tkr versus -8,121 tkr in Q3 2023, and 4,389 tkr for Jan–Sep 2024 compared to -44,300 tkr year-over-year.
Net asset value (NAV) per share rose 11% in Q3 to 4.27 kr, and reached 4.46 kr by October 31, 2024, up 4% since year-end.
Portfolio companies delivered double-digit revenue growth and improved profitability, especially in the services sector.
Financial highlights
NAV at period end: 123,782 tkr (171,980 tkr in 2023); NAV per share: 4.27 kr (5.36 kr in 2023).
Q3 total comprehensive income: 12,636 tkr (Q3 2023: -8,121 tkr); Jan–Sep: 4,389 tkr (Jan–Sep 2023: -44,300 tkr).
Result per share Jan–Sep: 0.15 kr (-1.32 kr in 2023); Q3: 0.44 kr (-0.25 kr in 2023).
Cash and equivalents at Q3 end: 3,768 tkr (22,855 tkr in 2023).
Equity at Q3 end: 123,782 tkr (171,980 tkr in 2023).
Outlook and guidance
Management is cautiously optimistic for 2025, focusing on cost efficiency and expecting positive effects from Chinese stimulus packages.
If Chinese inflation reaches 2–3% in 2025, portfolio companies could see significant growth.
Latest events from Collaxio
- Strategic shift to unlisted assets and acquisitions drove transformation, but NAV per share fell.COLLAX
Q4 202520 Feb 2026 - Strategisk omställning och portföljförvärv ledde till minskat substansvärde och negativt resultat.COLLAX
Q3 20257 Nov 2025 - Strategic pivot to unlisted investments, with NAV per share dropping and major portfolio acquisition.COLLAX
Q2 202528 Aug 2025 - Substansvärdet per stamaktie minskade 11% under H1 2024, men resultatet förbättrades.COLLAX
Q2 202413 Jun 2025 - Substansvärdet minskade 6% och hela portföljen föreslås avyttras med extrautdelning.COLLAX
Q1 20256 Jun 2025 - Stark vändning till positivt resultat och höjd utdelning trots lägre substansvärde.COLLAX
Q4 20245 Jun 2025